Welcome to our dedicated page for Valens Semiconductor Ltd. SEC filings (Ticker: VLN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Valens Semiconductor Ltd. filings document the company’s foreign-issuer current reports, semiconductor connectivity business, governance matters and capital-structure disclosures. Form 6-K reports furnish earnings releases, product announcements involving VA7000 A-PHY chipsets and automotive camera applications, annual meeting voting results, management-transition disclosure, and exhibits incorporated by reference into Form F-3 and Form S-8 registration statements.
The filing record also covers operating and financial results, material-event disclosures, risk factors and corporate governance under the company’s public-company reporting framework. These documents relate to Valens’ audio-video and automotive connectivity markets, including high-speed video and data transmission technologies tied to HDBaseT and MIPI A-PHY.
Valens Semiconductor Ltd. SVP R&D Chairman David filed an initial statement of beneficial ownership, reporting existing equity holdings in the company. The filing lists stock options over 9,938, 99,695 and 142,500 ordinary shares at exercise prices of 0.8603 and 2.2700, with expirations in 2031 and 2032. It also describes multiple restricted stock unit grants that vest over several years, subject to continued service, along with direct holdings of ordinary shares. The entry reflects current positions rather than new share purchases or sales.
Valens Semiconductor Ltd. executive Amir Boim, SVP Operations and PMO, filed an initial ownership report showing direct holdings of ordinary shares and several stock option grants. The options cover 9,938, 46,377 and 66,253 ordinary shares at an exercise price of 0.8603, and 135,000 shares at 2.2700, with expirations between 2029 and 2032. Footnotes explain that multiple restricted stock unit awards vest over multi‑year schedules, and one option grant is already fully vested and immediately exercisable while another vests in full on 06/26/2027.
Valens Semiconductor Ltd. director Ben Zvi Gideon filed a Form 3 reporting his existing holdings of ordinary shares and stock options in the company. The filing lists several stock option awards over ordinary shares with exercise prices ranging from $0.8600 to $5.3600 and expiration dates from 2029 through 2032, all held directly. It also shows multiple blocks of directly held ordinary shares. Footnotes explain that some shares were acquired by exercising previously granted options or purchased in the open market, and that both option and RSU grants generally vest 25% on an initial vesting date with the remaining 75% vesting in twelve equal quarterly installments, contingent on continued service.
VLN Form 144: This filing reports dispositions of Ordinary shares by Dror Jerushalmi. On 01/02/2026 he sold 254,131 shares for $463,648.70. On 02/02/2026 he sold 217,560 shares for $336,966.50.
The filing also lists securities to be sold under an Employee Stock Option Plan with cash upon exercise as the payment method; specific planned quantities or timing for that entry are not detailed in this excerpt.
Dror Jerushalmi reported sales of Ordinary shares under the Employee Stock Option Plan. The Form 144 lists three sales: 12/05/2025 of 42,631 shares for $72,760.69, 01/02/2026 of 254,131 shares for $463,648.70, and 02/02/2026 of 199,758 shares for $308,719.22. The transactions are described as cash upon exercise and identify Oppenheimer & Co. Inc. as the broker.
VLN filed a notice of proposed sale of 16,250 ordinary shares under an Employee Stock Option Plan, dated 02/25/2026, to be exercised for cash upon exercise.
The filing also discloses recent sales by Dror Jerushalmi: 12/05/2025 42,631 shares for $72,760.69, 01/02/2026 254,131 shares for $463,648.70, and 02/02/2026 183,508 shares for $283,531.72.
VLN insider reported proposed and recent sales of ordinary shares under an Employee Stock Option Plan. The filing lists proposed securities to be sold from the plan and three completed sales reported in the past three months: 12/05/2025 — 42,631 shares for $72,760.69; 01/02/2026 — 254,131 shares for $463,648.70; 02/02/2026 — 168,107 shares for $260,122.20.
The securities to be sold are listed as arising from an Employee Stock Option Plan with cash upon exercise noted as the method. The filing supplies holder and address details for the reporting person.
Valens Semiconductor Ltd. reported continued growth for Q4 and full year 2025, with quarterly revenue of $19.4M and full-year revenue of $70.6M, up from $57.9M in 2024, a 22% increase. Full-year gross margin improved to 62.4%.
The company remained loss-making but narrowed its net loss to $31.6M from $36.6M, while Adjusted EBITDA loss improved to $16.9M from $21.1M. Cash, cash equivalents and short-term deposits totaled $92.6M as of December 31, 2025. Management launched an operational efficiency plan expected to reduce annual operating expenses by about $5M and guided 2026 revenue to $75.0M–$77.0M (around 8% growth at the midpoint), with Q1 2026 revenue projected at $16.3M–$16.7M and a continued Adjusted EBITDA loss.
Valens Semiconductor filed its 2025 annual report outlining a cyclical semiconductor business exposed to global macro, supply-chain and pricing pressures. The company generated most 2025 revenue from cross-industry products, with automotive also significant, and about 15% of revenue coming from China, which is sensitive to evolving U.S. export controls.
Customer concentration remained high, as roughly 31% of 2025 revenue came from the top three customers, all buying through short‑term orders. The filing describes a 2024 quality incident that led to $2.2 million of expenses, followed by a partial reversal and an expected insurance recovery, as well as ongoing warranty and product liability risks.
Valens highlights competition, rapid technology change, and the need for continuous R&D, including after its 2024 acquisition of Acroname. It also notes a CEO transition in late 2025 and an efficiency plan announced in early 2026 that reduced the workforce by about 10%. Additional sections discuss exposure to currency volatility, cyber and AI-related risks, talent retention challenges and heavy reliance on third‑party manufacturing.
Dror Jerushalmi reported sales of ordinary shares under Rule 144. The filing lists three dispositions: 42,631 shares on 12/05/2025 for $72,760.69, 254,131 shares on 01/02/2026 for $463,648.70, and 167,008 shares on 02/02/2026 for $258,451.72. The excerpt also shows 106,342,415 ordinary shares as of 02/23/2026 as a context figure.